Investment Opportunity
Building the future of dementia care through behavioural intelligence and privacy-first monitoring
Executive Summary
Central-Core is building privacy-first, AI-powered behavioural monitoring for dementia care at home. Our plug-and-play system is designed to help families safely extend independent living while reducing the need for costly care home admissions. The product is at concept stage and pre-revenue; we are raising to build the MVP and run our first pilots.
The Problem
Existing solutions are invasive (cameras), unreliable (wearables), or require technical expertise (DIY smart home). 85% of dementia patients want to stay home, but families lack non-invasive monitoring tools.
Our Solution
Whole-home behavioural intelligence using privacy-safe sensors, designed for zero configuration. The AI is being built to learn individual routines and alert families to deviations before emergencies occur.
Stage & Status
Concept stage and pre-revenue. No deployments or customers yet. We are seeking funding to build the MVP and run our first pilots. Target channels: B2C, B2G (NHS / local authorities), and B2B.
Market Opportunity
Market Dynamics
Problem: The UK social care system is in crisis. With 700,000 unfilled care positions and £42B annual dementia care costs, families face impossible choices between inadequate home monitoring and expensive residential care.
Incumbent Solutions Fall Short:
- Camera-based systems: Privacy violations, legal consent issues, family resistance
- Wearable devices: Poor compliance rates (forgotten, removed, uncharged)
- DIY smart home: High technical barriers, no integrated AI, fragmented alerts
- Traditional telecare: Reactive only (falls, panic buttons), no preventative capability
Our Addressable Market
TAM (Total Addressable Market)
£15B annually
Global home-based dementia monitoring (55M patients × £270 average spend)
SAM (Serviceable Available Market)
£2.8B annually
UK + English-speaking markets (early adopters, tech-savvy families)
SOM (Serviceable Obtainable Market)
£140M by Year 5
5% penetration of UK/Ireland dementia home care market
Competitive Advantages & Defensibility
Our defensible moat is built on technical innovation, regulatory positioning, and operational excellence that competitors cannot easily replicate.
Privacy Architecture
Advantage: Zero PII collection. No cameras, no audio, no facial recognition.
Defensibility: Competitors cannot pivot away from camera-based systems without complete product redesign. Our privacy-first approach is GDPR-compliant by default and deployable globally without modification.
Behavioural AI Engine
Planned advantage: Proprietary machine learning models built for dementia-specific behaviour patterns (in development).
Defensibility: Each future deployment is intended to generate unique training data, creating a compound moat over time. More installations = better AI = higher accuracy = stronger market position.
Whole-Home Intelligence
Advantage: Multi-room sensor fusion creates complete behavioural picture.
Defensibility: Point solutions (single-room fall detectors, door sensors) cannot match our holistic insights. Switching costs increase as families rely on integrated intelligence.
Zero-Touch Deployment
Advantage: Pre-configured hubs. Plug-and-play activation. Remote management.
Defensibility: Operational excellence creates customer lock-in. Families will not switch from working systems that require zero maintenance.
Regulatory Freedom
Advantage: Non-medical device classification. No regional certification required.
Defensibility: Competitors pursuing medical device claims face 2-5 year certification cycles and market-specific approvals. We scale globally immediately.
Enterprise Infrastructure
Planned advantage: MQTT + Cloudflare Tunnel architecture designed to scale linearly from 10 to 100,000 devices.
Defensibility: Architecture chosen so no redesign is required for enterprise deployment, enabling capital-efficient scaling as we grow.
Competitive Landscape Analysis
| Feature | Central-Core | Camera Systems | Wearables | DIY Smart Home |
|---|---|---|---|---|
| Privacy Compliant | ✓ | ✗ | ~ | ~ |
| Zero User Effort | ✓ | ✓ | ✗ | ✗ |
| Behavioural AI | ✓ | ~ | ✗ | ✗ |
| Plug & Play Setup | ✓ | ~ | ✓ | ✗ |
| Whole-Home Coverage | ✓ | ✗ | ✗ | ~ |
| No Certifications | ✓ | ~ | ✗ | ✓ |
Business Model & Revenue Architecture
Planned multi-channel revenue model across B2C, B2G, and B2B segments. Figures below are targets and assumptions, not current results.
Direct to Consumer (B2C)
Target 60% of revenueCustomer Profile: Adult children caring for aging parents. Tech-comfortable, values peace of mind, willing to pay premium for dignity-preserving solution.
Target CAC: £120 | Target LTV: £2,400 (assumed 36-month tenure) | Target LTV:CAC: 20:1 (modelled assumptions, not yet observed)
Government & NHS (B2G)
Target 25% of revenueCustomer Profile: Local authority social care departments, NHS Trusts, telecare providers. Budget-constrained, evidence-driven, long sales cycles (6-12 months).
Value Proposition: Prevents costly care home admissions (£50K/year saved per patient). Reduces hospital readmissions. Improves social care outcomes.
Enterprise (B2B)
Target 15% of revenueCustomer Profile: Care home operators, sheltered housing providers, retirement communities. Seeking resident safety without cameras, brand-conscious.
Differentiation: Custom dashboards, branded resident portals, API integrations with care management systems.
Illustrative Financial Projections (5-Year)
Pre-revenue projections for illustration only. These are goals based on assumptions, not historical performance or commitments.
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Active Deployments | 500 | 2,000 | 5,000 | 12,000 | 25,000 |
| Annual Revenue | £250K | £1.2M | £3.5M | £9.2M | £22M |
| Gross Margin | - | 15% | 35% | 45% | 55% |
| Monthly ARPU | £28 | £32 | £35 | £38 | £40 |
| Annual Recurring Revenue | £140K | £640K | £1.75M | £4.5M | £10M |
Assumptions: 70% subscription attach rate, 36-month average customer lifetime, 8% monthly churn rate stabilizing to 5% by Year 3
Target Unit Economics (Projected)
Traction, Roadmap & Investment Opportunity
Current Status
We are at concept stage and pre-revenue. We are being upfront about where we are: no deployments, customers, or partnerships are in place yet. Here's the honest picture.
Pre-launch; first pilots planned after funding
Core platform and behavioural AI being built
Pre-revenue — validating demand and pricing
SEIS/EIS eligible — see the ask below
Growth Roadmap
2025 — Concept & Design
Product concept defined, privacy-first architecture designed, marketing site built
Now — Build MVP & Raise (Current)
Complete the MVP, close the seed round, then run first pilots and establish the B2C channel. NHS and local-authority conversations to follow.
Q3 2026 — Channel Expansion
200 active hubs, 2 local authority contracts, B2B partnerships, £50K MRR
Q4 2026 — Scale Preparation
1,000 deployments, £180K MRR, manufacturing partnership, Series A readiness
2027 — International Expansion
UK scale-up + US market entry, enterprise sales team, 5,000+ active hubs
Market Timing & Catalysts
🧩 Market Forces
- UK social care crisis (700K unfilled positions)
- NHS prioritizing preventative care technology
- Aging population acceleration (2M UK dementia cases by 2030)
- Family willingness to pay for peace of mind increasing
⚙️ Technology Maturity
- mmWave sensors now cost-effective (£15/unit vs £150 in 2020) - used as confirmatory sensors
- Open-source smart home ecosystem matured (500K+ active installations)
- Multi-sensor fusion algorithms can substantially reduce false positives
- Cloud AI inference economically viable for per-home deployment
- Cloudflare Tunnel democratized secure remote access
🚀 Regulatory Landscape
- GDPR enforcement pushing competitors away from camera-based systems
- EU MDR 2024 raising medical device certification barriers (our non-medical positioning is advantageous)
- UK Government "Ageing Society Grand Challenge" funding available
Seed Funding Round
- 40% — Hardware production & inventory
- 35% — Team expansion (2× engineers, 1× sales)
- 15% — Marketing & customer acquisition
- 10% — NHS pilot support & validation
12-Month Milestones (Post-Funding)
- 1,000 active deployments
- £180K monthly recurring revenue
- 3 local authority contracts signed
- Series A readiness (£2M+ ARR run-rate)
Partner With Us
Join us in building the future of dignity-preserving dementia care. Our technology extends independent living, prevents costly institutionalization, and brings peace of mind to millions of families globally.
This presentation contains forward-looking statements and is intended for sophisticated investors only. All financial projections are estimates based on current assumptions.